Imetelstat Treatment Information To Be Presented Tomorrow at Ash Annual Meeting at 4:30 PM

At the Ash Annual Meeting “463 Imetelstat Treatment Leads to Durable Transfusion Independence (TI) in RBC Transfusion-Dependent (TD), Non-Del(5q) Lower Risk MDS Relapsed/Refractory to…

Read more